Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Adalimumab 40 Mg / 0.8 Ml Pfs 40 Mg Inj
|
| Description |
Adalimumab 40 Mg / 0.8 Ml Pfs 40 Mg Inj
|
| Organisation | Bharat Heavy Electricals Limited | Public Sector Undertakings |
| Tender Id | 2024_BHEL_40204_1 |
|
Reference Number |
BPE2400388 |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | |
| Place | KASTURBA HOSPITAL BHEL BHOPAL |
| Link |
View Original Tender Notice
https://eprocurebhel.co.in/nicgep/app?page=FrontEndTenderDetailsExternal&service=page&tnid=41900 |
| Start Date | September 21, 2024 18:40 |
| End Date |
Expired
03/10/2024
Expired 641 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Pfs hyaluronic acid for ortho cases.1)sodium hyaluronic acid of higher concentration equal or more than 60mg/3ml.2)should be of higher molecular weight 5 million dalton.3)highly cross linked and stabilised for long duration of action.4)non avion source.5) certificate to be attached with the offer.
For complete deion and other details, please refer to tender
Read moreAdalimumab 40mg/0.8ml inj in pfs
For complete deion and other details, please refer to tender
Read moreAdalimumab 40mg/0.8ml inj in pfs
For complete deion and other details, please refer to tender
Read moreAdalimumab 40mg/0.8ml inj in pfs
For complete deion and other details, please refer to tender
Read moreAdalimumab 40mg/0.8ml inj in pfs
For complete deion and other details, please refer to tender
Read moreAdalimumab 40mg/0.8ml inj in pfs
For complete deion and other details, please refer to tender
Read moreAdalimumab 40mg/0.8ml inj in pfs
For complete deion and other details, please refer to tender
Read moreAdalimumab 40mg/0.8ml inj in pfs
For complete deion and other details, please refer to tender
Read moreInj. adalimumab 40mg/0.8ml in pfs
For complete deion and other details, please refer to tender
Read moreof your Industry type